drugs. Such information is highly relevant in the setting of personalized medicine for RA. 4 Miyadera et al. focus on molecular mechanisms that might account for the HLA-class II association with type 1 diabetes and RA. Here, based on their own observations, they propose a 'MHC stability model' which hypothesizes that the risk DQA1-DQB1 haplotype may be associated with type 1 diabetes through the production of unstable HLA-DQ molecules. 5 Further studies are needed to validate this fascinating hypothesis.
One of the striking characteristics of human immune system genes is the importance of multigene families. The immunoglobulin (Ig)-like receptor family is one such example. Ig-like receptor genes such as Fcγ receptor (FCGR) genes and killer-cell Ig-like receptor (KIR) genes have been associated with a number of diseases. Here, Hirayasu et al. 6 review another intriguing group of Ig-like receptor genes, leukocyte Iglike receptor (LILR) genes. LILR is a family composed of 11 functional genes (activating, inhibitory and soluble) and 2 pseudogenes. Although their biological functions are just beginning to emerge, some members of the LILR family work as receptors of HLA class I, and LILRA4 is expressed in the plasmacytoid dendritic cells and functions as an inhibitory receptor. Thus, the LILR family has an important role in the immune system, and in fact, a number of disease associations, including various autoimmune diseases and prostate cancer, have already been reported.
Finally, Hosomichi et al. discuss exciting progress on MHC research using next-generation sequencing (NGS). 7 NGS can overcome a number of previous limitations in MHC research; for example, conventional genotyping methods could only 'estimate' the alleles of an individual because of multiple heterozygous polymorphic positions. Using NGS, one can experimentally determine the 'phase' of the haplotype. The authors further emphasize the importance of regulatory region polymorphisms, which can affect the expression of HLA. Little is currently known with respect to the differences in the expression levels of individual HLA alleles. Thus, NGS analysis of MHC region will open a new era of 'HLA-omics'.
We sincerely thank the contributors and editorial staff who have made this unique review issue possible. We hope that the readers enjoy this issue, and we will be thrilled if this small collection of stimulating reviews is able to pave the way to close and fruitful collaboration between immunogenetics and population genetics.
